Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)
Clinical trial NCT04676724 · COMPLETED
Trial details
- NCT number
- NCT04676724
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2023-02-17
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.